Skane dairy to add Reuteri to milk products

Related tags Lactobacillus Nutrition

Leading Swedish dairy firm Skanemejerier has gained the rights to
use BioGaia's probiotic Reuteri bacteria in milk products for
launch on the Scandinavian market at the end of next year.

The Reuteri bacteria are already used by a number of dairy firms around the world but Skanemejerier represents a major deal for BioGaia as the dairy firm is already a significant player in the region's functional foods market and abroad.

The company was recently awarded Sweden's (and Europe's) first health claim to support the health benefits of probiotic bacteria, for its probiotic fruit juice ProViva. This drink contains Lactobacillus plantarum 299v​ (LP299v), licensed from another Swedish probiotics developer, Probi.

BioGaia has seen a number of new licensing deals this year. Swedish food manufacturer Procordia has also recently gained rights to the bacteria and is set to launch probiotic fruit beverages and fruit soups for the retail trade at the beginning of 2004.

The Reuteri bacteria are also available from Max Medica which sells Probiomax Reuteri tablets in natural health stores and Novartis (formerly Semper), selling Reuteri straws together with nutrition solutions for use in hospitals and health care institutions

"We have previously worked with Skanemejerier and it is clear that we have the same view of the market. We believe that together we will be able to develop a very interesting product range with the potential for rapid growth in this market,"​ said Peter Rothschild, managing director of BioGaia​.

Rolf Bjerndell, CEO and president of Skanemejerier, added that the agreement is fully in line with the firm's focus on healthier food products.

"We are continuously working to extend our range of health-promoting products and strengthen our position as the leading manufacturer in this segment,"​ he said.

In 2003, the total European probiotics market was estimated to be worth €34.6 million but it is expeted to more than triple, reaching €118.5 million in 2010, according to data from Frost & Sullivan.

Related news

Show more

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Custom Biotic Solutions for Digestive Health

Custom Biotic Solutions for Digestive Health

Content provided by ADM: Innovation that Feeds the Future | 10-Oct-2023 | White Paper

A growing body of evidence shows gut health can affect digestive health, well-being, and many health areas in between.

4 reasons children need MFGM, according to science

4 reasons children need MFGM, according to science

Content provided by Valio | 29-Sep-2023 | White Paper

In this white paper, Dr Anu Turpeinen discusses the ample scientific evidence showing why milk fat globule membrane (MFGM) is essential for children’s...

Related suppliers

Follow us


View more